Skip to main content

PERCEPTIVE ADVISORS LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1224962 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 29, 2026
Position Value
$8,569,687
-$38,383,134 QoQ
Shares Held
65,050
-80.4% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PERCEPTIVE ADVISORS LLC holds $200,430,720 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (4.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
65,050 $8,569,687

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,569,687 65,050
2025-12-31 $46,952,821 331,050
2025-09-30 $63,178,019 450,050
2025-06-30 $32,057,234 255,050
2025-03-31 $11,065,530 100,050
2024-12-31 $13,656,825 100,050
2024-09-30 $24,452,910 212,228
2024-06-30 $89,472,972 649,909
2024-03-31 $110,944,089 804,409
2023-12-31 $35,679,817 270,794
2023-09-30 $17,914,725 159,242
2023-06-30 $9,434,715 100,050
2023-03-31 $10,127,061 100,050
2022-12-31 $11,949,972 100,050
2022-09-30 $10,626,310 100,050
2022-06-30 $38,786,122 397,888
2022-03-31 $37,091,156 395,639
2021-12-31 $41,137,706 483,007
2021-09-30 $46,325,201 483,007
2021-06-30 $79,007,490 811,832
2021-03-31 $91,593,162 941,832
2020-12-31 $182,039,757 1,899,215
2020-09-30 $148,924,434 1,548,715
2020-06-30 $261,252,020 2,141,410
2020-03-31 $265,125,412 3,063,263